Formycon AG v. Regeneron Pharmaceuticals, Inc. > Summary
Court Case Number IPR2025-00233
Filing Date Dec 2, 2024
Institution Decision Date Jun 2, 2025
Decision Date Jun 2, 2025
Court Patent Trial and Appeal Board
Status Institution Denied
Administrative JudgesMichael A. Valek, Susan L. C. Mitchell, Jamie T. Wisz
Judge Writing the Final DecisionMichael A. Valek
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 19, 20, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 39, 40, 41, 42, 44, 45, 47, 48, 49, 50, 51, 52, 53, 54, 55
Patent Owner
Petitioner Attorneys
4Formycon Ag
Attorney Name: Louis E. Fogel
Fish & Richardson
Formycon Ag
Attorney Name: Grace Jinsil Kim
Fish & Richardson
Formycon Ag
Attorney Name: Anastasia Renard
Fish & Richardson
Formycon Ag
Attorney Name: Kristi L. R. Sawert
Fish & Richardson
Patent Owner Attorneys
5Regeneron Pharmaceuticals
Attorney Name: David I. Berl
Williams & Connolly
Regeneron Pharmaceuticals
Attorney Name: Elizabeth S. Weiswasser
Paul Weiss Rifkind Wharton & Garrison
Regeneron Pharmaceuticals
Attorney Name: Andrew V. Trask
Williams & Connolly
Regeneron Pharmaceuticals
Attorney Name: Priyata Y. Patel
Paul Weiss Rifkind Wharton & Garrison
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11084865 | VEGF antagonist formulations suitable for intravitreal administration | Aug 10, 2021 |
